What is MRK's current stock price?

As of now, MRK is trading at $87.69, with a daily change of +0.56%.

What are the risks associated with MRK stock?

MRK Key risk is its Low Risk Level, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

MRK Stock Analysis & IQ Rating | Merck Company

MRK

Merck Company

$87.69

+$0.49 | +0.56%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 106.49

MKT CAP

$ 219.04B

52W Low

$ 73.31

VOL

$ 1.30M

P/E Ratio

13.52

AVG VOL

$ 12.54M

RSI

59.47

TREND

Uptrend

alert Latest Updates

OptionSpotter Yesterday at 05:13

Affirm Holdings saw heavy options flow yesterday as large investors took a bullish stance after the close. The surge in call activity suggests institutions or wealthy traders might be positioning for an upside move. As t...

MRK Stock IQ

Login to see Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

MRK Target Price

Login to display

Strengths

MRK Rewards

Earnings are forecast to grow

MRK Rewards

Trading below its fair value

MRK Rewards

Upgraded on attractively valued

Risk Analysis

MRK Risk Analysis

Investors losing their confidence

Chart

$78.56 (+11.62%)

$80.17 (+9.38%)

$77.14 (+13.68%)

$100.73 (-12.95%)

1year

6month

3month

1month

MRK Risk Level

MRK has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

MRK Analysts Opinion

MRK overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

MRK Analysts Opinion

MRK Analysts opinion is positive but there was a setback from the past 3 months

MRK Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

51%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

40%

48%

MRK Street Opinion

MRK Street view is bullish and have positive views on the near-term outlook

MRK Performance Sentiment

Sentiments overview associated with MRK events and the stock performance.

51%

12%

Positive

Negative

21 out of 41
events present

5 out of 41
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$87.09

Resistance
Price

$77.60

Current Price Range

$90.13

Show methods +

Linked to MRK

IQ

Close Price

Change

NVS

4.26

130.80

-0.60%

AZN

4.18

82.96

-0.53%

PFE

4.09

24.72

+0.14%

SNY

3.81

51.43

+3.84%

LLY

4.20

829.71

+0.91%

MRK Latest Analysis +

Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies | DelveInsight. Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies |. DelveInsightThe hidradenitis suppurativa market is poised for strong growth driven by increasing disease awareness earlier diagnosis and expanding treatment access. Advances in biologic and targeted therapies particularly the emergen

Thu Oct 23, 2025

$87.18 | -0.55%

Activity

Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release. Merck (MRK) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thu Oct 23, 2025

$87.18 | -0.55%

Earnings

Potential

Guru Fundamental Report for MRK - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Thu Oct 23, 2025

$87.18 | -0.55%

Potential

FDA Grants Priority Review For Mercks KEYTRUDA And KEYTRUDA QLEX SBLAs In MIBC . (RTTNews) - Merck & Co Inc. (MRK) on Thursday said that the United States Food and Drug Administration (FDA) has granted priority review for two supplemental Biologics License Applications (sBLA) for KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph

Thu Oct 23, 2025

$87.18 | -0.55%

Activity

MRK Quantitative Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Tue Oct 21, 2025

$87.62 | +1.54%

Potential

Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Mon Oct 20, 2025

$86.32 | +1.80%

Potential

Will Declining Gardasil Sales Ail MRKs Top Line in Q3 Earnings?. Merck faces a sharp Gardasil slowdown as weak demand in China and Japan affects sales of the vaccine.

Fri Oct 17, 2025

$84.79 | +1.04%

Activity

Invo Fertility Stock Is Plunging After White House Announcement. ) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments .) to dramatically cut the cost of IVF medications. Under the agreement Merck'.s fertility drugs — like Gonal-f Ovidrel and Cetrotide — will be heavily discounted when used for IVF treatment saving patients approximately $2200 per treatment cycle.In return for the price reductions Merck will

Fri Oct 17, 2025

$84.79 | +1.04%

Momentum

Potential

Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Fri Oct 17, 2025

$84.79 | +1.04%

Potential

Bank of America Securities Reduces PT on Merck & Co. Inc. (MRK) Keeps a Buy Rating.

Fri Oct 17, 2025

$84.79 | +1.04%

Rating

FAQ About MRK Stock Insights

What is MRK current stock price?

What are MRK stock strengths?

What risks are associated with MRK stock?

When is MRK next earnings report?

What is MRK market cap and volume?

What is MRK's current Stock IQ?

Should I buy MRK stock right now?

Is MRK a Strong Buy right now?

What does a 'Strong Buy' rating mean for MRK?

What does a 'Strong Sell' rating mean for MRK?

What factors influence MRK's Stock IQ?

Explore our MRK Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored MRK Stock Strategies
Effective Risk Management

FIND US ON

Receive our MRK Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

MRK

Merck Company

Current Price

$87.69

+$0.49 | +0.56%

52W High

$ 106.49

MKT CAP

$ 219.04B

52W Low

$ 73.31

VOL

$ 1.30M

P/E Ratio

13.52

AVG VOL

$ 12.54M

RSI

59.47

TREND

Uptrend

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

MRK Rewards

Earnings are forecast to grow

MRK Rewards

Trading below its fair value

MRK Rewards

Upgraded on attractively valued

Risk Analysis

MRK Risk Analysis

Investors losing their confidence

Linked to MRK

Symbol

IQ

Close

Change

NVS

4.26

130.80

-0.60%

AZN

4.18

82.96

-0.53%

PFE

4.09

24.72

+0.14%

SNY

3.81

51.43

+3.84%

LLY

4.20

829.71

+0.91%

MRK Stock IQ

Login to unlock Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$78.56 (+11.62%)

$80.17 (+9.38%)

$77.14 (+13.68%)

$100.73 (-12.95%)

1year

6month

3month

1month

MRK Analysts Opinion

MRK Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

MRK Analysts Opinion

MRK Analysts opinion is positive but there was a setback from the past 3 months

MRK Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

51%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

40%

48%

MRK Street Opinion

MRK Street view is bullish and have positive views on the near-term outlook

MRK Risk Level

MRK has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

MRK Performance Sentiment

Sentiments overview associated with MRK events and the stock performance.

51%

12%

Positive

Negative

21 out of 41
events present

5 out of 41
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$87.09

Resistance
Price

$77.60

Current Price Range

$90.13

Show methods +

MRK Latest Analysis

OptionSpotter Yesterday at 05:13

Affirm Holdings saw heavy options flow yesterday as large investors took a bullish stance after the close. The surge in call activity suggests institutions or wealthy traders might be positioning for an upside move. As t...

Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies | DelveInsight. Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies |. DelveInsightThe hidradenitis suppurativa market is poised for strong growth driven by increasing disease awareness earlier diagnosis and expanding treatment access. Advances in biologic and targeted therapies particularly the emergen

Thu Oct 23, 2025

$87.18 | -0.55%

Activity

Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release. Merck (MRK) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thu Oct 23, 2025

$87.18 | -0.55%

Earnings

Potential

Guru Fundamental Report for MRK - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Thu Oct 23, 2025

$87.18 | -0.55%

Potential

FDA Grants Priority Review For Mercks KEYTRUDA And KEYTRUDA QLEX SBLAs In MIBC . (RTTNews) - Merck & Co Inc. (MRK) on Thursday said that the United States Food and Drug Administration (FDA) has granted priority review for two supplemental Biologics License Applications (sBLA) for KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph

Thu Oct 23, 2025

$87.18 | -0.55%

Activity

MRK Quantitative Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Tue Oct 21, 2025

$87.62 | +1.54%

Potential

Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Mon Oct 20, 2025

$86.32 | +1.80%

Potential

Will Declining Gardasil Sales Ail MRKs Top Line in Q3 Earnings?. Merck faces a sharp Gardasil slowdown as weak demand in China and Japan affects sales of the vaccine.

Fri Oct 17, 2025

$84.79 | +1.04%

Activity

Invo Fertility Stock Is Plunging After White House Announcement. ) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments .) to dramatically cut the cost of IVF medications. Under the agreement Merck'.s fertility drugs — like Gonal-f Ovidrel and Cetrotide — will be heavily discounted when used for IVF treatment saving patients approximately $2200 per treatment cycle.In return for the price reductions Merck will

Fri Oct 17, 2025

$84.79 | +1.04%

Momentum

Potential

Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Fri Oct 17, 2025

$84.79 | +1.04%

Potential

Bank of America Securities Reduces PT on Merck & Co. Inc. (MRK) Keeps a Buy Rating.

Fri Oct 17, 2025

$84.79 | +1.04%

Rating

Discover MRK Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRK. We're here to help you make informed investment decisions today.

FIND US ON

Receive our MRK Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MRK Stock trends

MRK Stock performance

MRK Stock analysis

MRK investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRK

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRK

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

MRK Stock Analysis & IQ Rating | Merck Company

MRK Stock IQ

MRK Target Price

MRK Risk Level

MRK Analysts Opinion

MRK Street Consensus

MRK Performance Sentiment

Technical Price Levels

Explore our MRK Stock insights

Receive our MRK Daily Alerts

MRK Stock IQ

MRK Street Consensus

MRK Risk Level

Technical Price Levels

Discover MRK Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRK. We're here to help you make informed investment decisions today.

Receive our MRK Daily Alerts

MRK Runner Alarm